Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s539. https://doi.org/10.25251/skin.10.supp.539